Central effects of thyronamines on glucose metabolism in rats

Journal of Endocrinology

Volumn 201, Issue 3, 2009, Pages 377-386

  Klieverik, Lars P ^a   Foppen, Ewout ^a,b   Ackermans, Mariëtte T ^a   Serlie, Mireille J ^a   Sauerwein, Hans P ^a   Scanlan, Thomas S ^c   Grandy, David K ^c   Fliers, Eric ^a   Kalsbeek, Andries ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYRONAMINE; CORTICOSTERONE; GLUCAGON; GLUCOSE; INSULIN; LIOTHYRONINE; THYROID HORMONE; THYRONAMINE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; THYRONINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; ISOTOPE DILUTION ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; CARBOHYDRATE METABOLISM; DOSE RESPONSE; DRUG EFFECT; HOMEOSTASIS; INFUSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCAGON; GLUCOSE; HOMEOSTASIS; INFUSIONS, PARENTERAL; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; INSULIN; MALE; RATS; RATS, WISTAR; THYRONINES;

EID: 67849087149     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0043     Document Type: Article

References (34)

1. 2O are higher than those measured with [2-(13)C]glycerol. Journal of Clinical Endocrinology and Metabolism 86 2220-2226.
2. Ackermans MT, Klieverik LP, Endert E, Sauerwein HP, Kalsbeek A & Fliers E 2008 Plasma insulin concentrations during a hyperinsulinaemic clamp: what do we measure? Annals of Clinical Biochemistry 45 429-430.
3. Adler SM & Wartofsky L 2007 The nonthyroidal illness syndrome. Endocrinology and Metabolism Clinics of North America 36 657-672.
4. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ & Fliers E 2005 Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 154 491-500.
5. Angel I, Niddam R & Langer SZ 1990 Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia. Journal of Pharmacology and Experimental Therapeutics 254 877-882.
6. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E & Wiersinga WM 2004 Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. Journal of Endocrinology 182 315-323.
7. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S et al. 2001 Trace amines: identification of a family of mammalian G protein-coupled receptors. PNAS 98 8966-8971.
8. Braulke LJ, Klingenspor M, Debarber A, Tobias SC, Grandy DK, Scanlan TS & Heldmaier G 2007 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. Journal of Comparative Physiology 178 167-177.
9. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL et al. 2001 Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular Pharmacology 60 1181-1188.
10. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, Debarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK et al. 2007 Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB Journal 21 1597-1608.
11. Dhillo WS, Bewick GA, White NE, Gardiner JV, Thompson EL, Bataveljic A, Murphy KG, Roy D, Patel NA, Scutt JN et al. 2008 The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes, Obesity and Metabolism 11 251-260.
12. Doyle KP, Suchland KL, Ciesielski TM, Lessov NS, Grandy DK, Scanlan TS & Stenzel-Poore MP 2007 Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 38 2569-2576.
13. Dratman MB, Crutchfield FL & Schoenhoff MB 1991 Transport of iodothyronines from bloodstream to brain: contributions by blood:brain and choroid plexus:cerebrospinal fluid barriers. Brain Research 554 229-236.
14. Fliers E, Guldenaar SE, Wiersinga WM & Swaab DF 1997 Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 82 4032-4036.
15. Grandy DK 2007 Trace amine-associated receptor 1-family archetype or iconoclast? Pharmacology and Therapeutics 116 355-390.
16. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK & Scanlan TS 2006 Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. Journal of Medicinal Chemistry 49 1101-1112.
17. Kalsbeek A, Fliers E, Franke AN, Wortel J & Buijs RM 2000 Functional connections between the suprachiasmatic nucleus and the thyroid gland as revealed by lesioning and viral tracing techniques in the rat. Endocrinology 141 3832-3841.
18. Kalsbeek A, La FS, Van HC & Buijs RM 2004 Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. Journal of Neuroscience 24 7604-7613.
19. Klieverik LP, Sauerwein HP, Ackermans M, Boelen A, Kalsbeek A & Fliers E 2008 Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. American Journal of Physiology. Endocrinology and Metabolism 294 513-520.
20. Lechan RM & Fekete C 2005 Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15 883-897.
21. Li DP, Atnip LM, Chen SR & Pan HL 2005 Regulation of synaptic inputs to paraventricular-spinal output neurons by alpha2 adrenergic receptors. Journal of Neurophysiology 93 393-402.
22. Liggett SB 2004 The two-timing thyroid. Nature Medicine 10 582-583.
23. Niswender KD & Schwartz MW 2003 Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Frontiers in Neuroendocrinology 24 1-10.
24. Obici S, Zhang BB, Karkanias G & Rossetti L 2002 Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medicine 8 1376-1382.
25. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B & Kohrle J 2008 Thyronamines are isoenzyme specific substrates of deiodinases. Endocrinology 149 3037-3049.
26. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L & Rossetti L 2005 Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434 1026-1031.
27. Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M & Coughlin SR 2007 Probing cell type-specific functions of G(i) in vivo identifies GPCR regulators of insulin secretion. Journal of Clinical Investigation 117 4034-4043.
28. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S et al. 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nature Medicine 10 638-642.
29. Snead AN, Santos MS, Seal RP, Miyakawa M, Edwards RH & Scanlan TS 2007 Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chemical Biology 2 390-398.
30. Steele R 1959 Influences of glucose loading and of injected insulin on hepatic glucose output. Annals of the New York Academy of Sciences 82 420-430.
31. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, Larsen PR & Lechan RM 1997 Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138 3359-3368.
32. Wainscott DB, Little SP, Yin T, Tu Y, Rocco VP, He JX & Nelson DL 2007 Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. Journal of Pharmacology and Experimental Therapeutics 320 475-485.
33. Weatherman RV 2007 A triple play for thyroid hormone. ACS Chemical Biology 2 377-379.
34. Zhu MY & Juorio AV 1995 Aromatic L-amino acid decarboxylase: biological characterization and functional role. General Pharmacology 26 681-696.